Timolol maleate is a nonselective beta-adrenergic receptor antagonist that is widely used for the treatment of glaucoma. We report a case of fatal bronchospasm that developed in an 82-year-old woman a ...

Please provide your email address to receive an email when new articles are posted on . Timolol maleate 0.5% microdrops delivered with a volume-reducing adaptor provided noninferior IOP reduction ...

While the pilot study successfully explored the efficacy of timolol eyedrops, further research is necessary to identify patients who would benefit the most from this treatment and an appropriate ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. OTTAWA — Health Canada has warned patients with ocular ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- The Rho kinase inhibitor netarsudil (Rhopressa) ...

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate ...

Compr Ophthalmol Update. 2005;6(2):85-101. In summary, the aqueous suppressors timolol gel once daily and brinzolamide are recommended first-line glaucoma agents often used together, with timolol gel ...

Glaukos’ intraocular implant has performed comparably to topical timolol in the 24-month interim analysis of glaucoma patients enrolled in a phase 2b trial. The study is part of Glaukos’ preparations ...

Glaukos has reported wins in a pair of late-phase clinical trials, teeing it up to seek FDA approval of its travoprost intraocular implant next year. The studies found the implant was noninferior to ...

A man accidentally glued his eye shut after mistaking nail glue for his eye drops. The 64-year-old immediately rinsed his eye under running water but two hours later the pain did not subside and he ...

The FDA approved the travoprost intracameral implant (iDose TR) for treatment of ocular hypertension and glaucoma, device developer Glaukos announced on Thursday. The implant is designed to provide ...